Metacrine-Logo-R Transparent.png.png
Metacrine Accelerates MET409 Clinical Development Milestone and Reports First-Quarter 2021 Results
May 13, 2021 16:05 ET | Metacrine, Inc.
• Topline results from a Phase 2a trial of MET409 in combination with empagliflozin in patients with NASH and type 2 diabetes now expected in the fourth quarter of 2021 • Interim data from the...
Metacrine-Logo-R Transparent.png.png
Metacrine Appoints Dr. Julia C. Owens to Its Board of Directors
April 05, 2021 16:05 ET | Metacrine, Inc.
SAN DIEGO, April 05, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with liver and...
Sonic Incytes_Secondary_Colour.jpg
Sonic Incytes Announces FDA Clearance and US Launch of Velacur™ to Help Manage Emerging Health Crisis
October 20, 2020 10:00 ET | Sonic Incytes Medical Corp.
VANCOUVER, British Columbia, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Sonic Incytes Medical Corporation is pleased to announce the US commercial release of VelacurTM, the world’s first handheld 3D liver...
AMR Logo.png
North America Liver Disease Treatment Market to Hit $8.31 Billion by 2027: AMR
October 20, 2020 09:26 ET | Allied Market Research
Portland, OR, Oct. 20, 2020 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the North America Liver Disease Treatment Market accounted for $6.97 billion in 2019, and is...
ritter.jpg
Ritter Pharmaceuticals, Inc. and Qualigen, Inc. Announce Merger Agreement
January 21, 2020 09:15 ET | Ritter Pharmaceuticals, Inc.
Transaction to Create a Nasdaq-listed Biotechnology Company Focused on Advancing Qualigen’s Cancer and Infectious Disease Therapeutic Development Programs LOS ANGELES, Jan. 21, 2020 (GLOBE...
avicorelogo.png
New Pharmacy Partnership Optimizes Patient Care Through Data Driven Solutions
January 21, 2020 07:30 ET | Avricore Health Inc.
VANCOUVER, British Columbia, Jan. 21, 2020 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) and the Ontario Pharmacists Association (OPA) are...
avicorelogo.png
Ontario Pharmacists and Avricore Health Partner to Expand HealthTab™ in Community Pharmacies and Enhance Patient Care
November 18, 2019 08:30 ET | Avricore Health Inc.
VANCOUVER, British Columbia, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) and the Ontario Pharmacists Association (OPA) are...
Metacrine-Logo-R.jpg
Metacrine to Present at Jefferies 2019 London Healthcare Conference
November 18, 2019 07:30 ET | Metacrine, Inc.
SAN DIEGO, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and...
ritter.jpg
Ritter Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2019 and Provides Business Update
November 13, 2019 19:35 ET | Ritter Pharmaceuticals, Inc.
LOS ANGELES, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of therapeutic products that modulate the gut...
Metacrine-Logo-R.jpg
Metacrine Secures $50 Million Growth Capital Facility from K2 HealthVentures
September 18, 2019 07:30 ET | Metacrine, Inc.
SAN DIEGO, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and...